ArticleInternational journal of hematology-oncology and stem cell research2018

Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre.

Mohith Saxena et al.PubMed ↗Full text ↗

No numbers read from the abstract.